The FDA laid out guidance to allow overseas baby-formula makers to stay in the U.S. market
Federal health regulators outlined plans Friday that will allow overseas baby-formula makers to continue selling their products in the U.S. long term following aOverseas makers of baby formula must send a letter to the U.S. Food and Drug Administration by Dec.
5 stating their intent to continue formula sales and that they will complete all regulatory requirements, according to guidance issued by the agency. The FDA will evaluate requests before deciding by Jan. 6, 2023, whether to allow global baby-formula makers to stay in the U.S. market.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA proposes updates to ‘healthy’ claim on food packagesThe changes come on the same day the White House released a new national strategy to end hunger and improve nutrition and physical activity.
Les mer »
New FDA baby formula warning: Stop using this recalled formula right nowFDA issued a warning for Mother’s Touch baby formula, and a recall followed - here’s what parents should know.
Les mer »
FDA to Explore Nutrition Labels on Front of PackagesThe Biden administration is pushing to change nutrition labels on food packaging to help people eat better and to encourage manufacturers to make healthier products. One change would be putting some form of food labels on the front of packaging.
Les mer »
FDA approves ALS drug whose study was partly funded by Ice Bucket Challenge | CNNThe US FDA has approved a new ALS drug that was backed by patients and advocacy groups. Its study had been partly funded by the viral Ice Bucket Challenge.
Les mer »
FDA Clears Nexpowder Endoscopic Hemostasis SystemFDAapproves the Nexpowder endoscopic hemostasis system. Using a powder that's sprayed through a catheter and featuring a proprietary powder-coating technology to reduce clogging, it improves visibility, control for treating upper GI bleeds. GastroTwitter
Les mer »